TipRanks

Evert B. Schimmelpennink Insider Profile

11 Followers
Evert B. Schimmelpennink, Director at Contineum Therapeutics, Inc. Class A, holds ― shares in Contineum Therapeutics, Inc. Class A (Ticker: CTNM), holds 26.66K shares in Pfenex (Ticker: PFNX), holds ― shares in Ibio (Ticker: IBIO). Most recently, Evert B. Schimmelpennink ― shares of Contineum Therapeutics, Inc. Class A on ― for an estimated value of ―.
tipranks
Evert B. Schimmelpennink

Evert B. Schimmelpennink
Contineum Therapeutics, Inc. Class A (CTNM)
Director

Ranked #45,098 out of 109,193 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+17.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$297K
100.00%
0.00%
0.00%
A breakdown of Evert B. Schimmelpennink's holdings

Insider Roles

LENZ Therapeutics
(LENZ)
President, CEO and Secretary, Director
Contineum Therapeutics, Inc. Class A
(CTNM)
Director
Ibio
(IBIO)
Director
Roles that Evert B. Schimmelpennink holds in companies

Most Profitable Insider Trade

Stock:
Pfenex
(PFNX)
Rating:Informative Buy
Date:Sep 13, 2018 - Sep 13, 2019
Return:+88.40%
The most profitable trade made by Evert B. Schimmelpennink

Evert B. Schimmelpennink's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Contineum Therapeutics, Inc. Class A
―
Director
―
―
PFNX
Pfenex
Sep 13, 2018
―
Informative Buy
50.38K
$339.89K
Ibio
―
Director
―
―
LENZ Therapeutics
Mar 30, 2026
President, CEO and Secretary, Director
Informative Buy
251.40K
$296.79K
List of latest transactions for each holding click on a transaction to see Evert B. Schimmelpennink's performance on stock

Evert B. Schimmelpennink insider profile FAQ

What is the percentage of profitable transactions made by Evert B. Schimmelpennink?
The percentage of profitable transactions made by Evert B. Schimmelpennink is 50%.
    What is the average return per transaction made by Evert B. Schimmelpennink?
    The average return per transaction made by Evert B. Schimmelpennink is 17.80%.
      What stocks does Evert B. Schimmelpennink hold?
      Evert B. Schimmelpennink holds: CTNM, PFNX, IBIO, LENZ stocks.
        What was Evert B. Schimmelpennink’s latest transaction?
        Evert B. Schimmelpennink latest transaction was an Uninformative Buy of ―.
          What was Evert B. Schimmelpennink's most profitable transaction?
          Evert B. Schimmelpennink’s most profitable transaction was an Informative Buy of PFNX stock on September 13, 2018. The return on the trade was 88.40%.
            What is Evert B. Schimmelpennink's role in Contineum Therapeutics, Inc. Class A?
            Evert B. Schimmelpennink's role in Contineum Therapeutics, Inc. Class A is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.